• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦EvidencePulse™by 2 Minute Medicine3 reportsYou askedtop stroke trials 2026Synthesizing medical evidence...Top 2026 stroke trial results:OCEANIC — ischemic stroke: 6.2% vs 8.4%OPTION* — mRS 0–1: 43.6% vs 34.2%ORIENTAL* — mRS 0–2: 58.6% vs 46.6%*Higher sICH in intervention armsParticipants randomizedNOCEANIC12,327OPTION570ORIENTAL564Ask about guidelines or landmark trials...↑Try EvidencePulse™Ask the evidence. Get the signal.Try it now →
Home All Specialties

Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers

byNicolette Overton, MSandAndrew Cheung, MD MBA
November 21, 2026
in All Specialties, Emergency, Imaging and Intervention, Orthopedic Surgery, Public Health
Reading Time: 3 mins read
Back CT scan collage: a ring-shaped CT scanner with its table, a stack of lower back vertebrae and a blank film sheet
Share on FacebookShare on TwitterShare on LinkedIn

1. Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers.

Evidence Rating Level: 3 (Average)

Study Rundown: Low back pain is a common cause of emergency department (ED) visits and accounts for the highest estimated health care costs along with neck pain. In the ED, lumbar imaging for nontraumatic back pain is discouraged per Choosing Wisely guidelines, but nearly a third of LBP ED patients are imaged. Hood and colleagues performed a retrospective, single-health-system observational comparison with 16,754 total imaging studies from 15,822 patients seen in urgent care centers (UCCs) and EDs to assess follow-up imaging in the ED across seven years. They found that 24 of 2,869 patients (0.82%, Wilson 95% CI 0.55–1.22%) who underwent lumbar radiography for LBP at UCCs had an ED visit with CT or MRI within 30 days. This trend was consistent across age groups and years included in the study. In addition, the researchers evaluated resource intensity of imaging studies by location through relative value units (RVUs), which were converted to estimated Medicare-allowed payments; these figures represent payments for the imaging studies, not total costs or cost-effectiveness. This showed an almost four-fold lower estimated imaging payment for radiographs at UCCs than for CT or MRI in EDs for LBP. Limitations of this study include the use of only one health system, patient and clinician preference differences, and lack of patient-reported outcomes. Because the source was unavailable, the full study population, site characteristics, statistical methods, adjustment for confounding, and whether the reported primary outcome and cost calculations match the publication could not be checked.

Click to read the study in the JACR (Journal of the American College of Radiology)

Click to read an additional editorial from the publishing laboratory

In-Depth [retrospective cohort study]: Hood and colleagues conducted a multi-site, retrospective cohort study within a single health system of adults 18 years of age and older who had lumbar spine imaging between January 1, 2019 and December 31, 2025. Sites included multiple EDs and 23 UCCs. Cohorts were divided into ED, which included CTs and MRIs of the lumbar spine, and UCC cohorts, which included lumbar or lumbosacral spine radiology. In total, 16,754 imaging studies were included; 2,924 were UCC lumbar radiographs and 13,830 were ED CT (n=12,983) or MRI (n=847). Any studies with red-flag presentations, including high-impact trauma, infection, malignancy, and neurologic compromise, were excluded. The UCC cohort included 2,869 patients and the ED cohort included 12,953 patients. The median interval between repeat imaging studies was 23 months (IQR 12-32) in the UCC cohort and 11 months (IQR 4-22) in the ED cohort; these intervals provide context for interpreting the 30-day follow-up outcome. Only patients who presented with low-acuity back pain were included. The index visit was the initial UCC visit for lumbar radiography, and a return visit was an ED visit for lumbar CT or MRI within 30 days of that index visit; 24 UCC patients had such a return visit. The primary outcome was the number of UCC radiology studies relative to the number of ED CT or MRI studies done in the next 30 days. In the UCC cohort, 24 of 2,869 patients (0.82%, Wilson 95% CI 0.55–1.22%) had ED CT or MRI in the next 30 days, with no additional repeat visits after the first for any patient. Median length of time was two days (IQR 0–6) for return visit to ED, while 50% (n=12) had their return visit within 24 hours. Secondary outcomes included 24-hour and seven-day return rates, length of time to first ED CT or MRI, and total RVUs translated into estimated Medicare-allowed payments In the UCC cohort, the median total RVU was 1.43 (IQR 1.40–1.44), which is approximately $48 Medicare-allowed payment per study. In the ED cohort, the median total RVU was 5.14 (IQR 5.05–6.50), which is approximately $171 Medicare-allowed payment per study. Overall, this study found lower estimated imaging payment for UCC radiographs than for ED CT or MRI among patients with low-acuity back pain; because this was a retrospective observational comparison, the UCC and ED groups may have differed in patient characteristics, clinical indications, and clinician or patient selection.

RELATED REPORTS

Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity

In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications

© 2026 2 Minute Medicine, Inc. All rights reserved. No part of this article may be reproduced, distributed or transmitted in any form or by any means without the prior written permission of 2 Minute Medicine, Inc. To license this content, contact 2 Minute Medicine, Inc. This article is for informational and educational purposes only; it is not medical advice and does not replace the judgment of a qualified healthcare professional.
Image: © 2 Minute Medicine

Tags: back painhealthcaremedicinepainstudy
Previous Post

A 34-circular RNA blood signature predicted Alzheimer’s disease progression and improved prediction when combined with pTau217

Next Post

Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity

RelatedReports

Asthma collage of a calm young man beside an engraved branching airway, an inhaler with a spacer and a sprig of grass pollen
Chronic Disease

Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity

November 21, 2026
An abstract representation featuring a syringe, pills, a silhouette of a person, and molecular structures, suggesting themes related to obesity treatment.
All Specialties

In a phase 3 trial, tirzepatide reduced BMI versus placebo in adolescents with obesity and obesity-related complications

November 19, 2026
Collage for angina: an older man in profile, a heart with one artery pinched by a blue band, a staircase and a wool scarf
Weekly Rewinds

2 Minute Medicine Rewind November 16, 2026

November 17, 2026
Knee osteoarthritis collage: a calm older man with a gray beard, a knee joint inset with teal cartilage and a knee brace
Endocrinology

Investigational retatrutide reduced knee osteoarthritis pain and body weight versus placebo in adults with obesity

November 17, 2026
Next Post
Asthma collage of a calm young man beside an engraved branching airway, an inhaler with a spacer and a sprig of grass pollen

Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity

✦ EvidencePulse™ by 2 Minute Medicine 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Long-term use of mometasone (Asmanex) in adults with sickle cell disease without formal diagnosis of asthma may worsen disease activity
  • Few patients had ED lumbar CT or MRI within 30 days after low-acuity back-pain radiography at urgent care centers
  • A 34-circular RNA blood signature predicted Alzheimer’s disease progression and improved prediction when combined with pTau217
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ new physician-written study summaries monthly, 12,000+ searchable
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓FDA drug approvals + clinical calculators

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • Medical Calculators
    • Clinical Guidelines
    • Physician Pay by Specialty
    • FDA Drug Approvals
    • RVU Search
    • ICD-10 Code Lookup
    • Drug Safety for Breastfeeding/Pregnancy
    • ECG Reference
      • QTc Calculator
      • Sgarbossa Criteria
      • ECG Axis Calculator
      • AV Block Helper
    • NPI Registry Lookup
  • Rankings
    • Medical School Rankings
    • Residency Rankings
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.